This inventor holds 3 USPTO granted patents. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 1999-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2004
Title: Shmuel Banai: Innovator in Pharmaceutical Research
Introduction
Shmuel Banai is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds. With a total of 3 patents to his name, Banai's work has the potential to impact various therapeutic areas.
Latest Patents
Among his latest patents is the invention of PDGF receptor kinase inhibitory compounds, which includes their preparation, purification, and pharmaceutical compositions. This groundbreaking work aims to provide new avenues for treatment in diseases where PDGF receptor activity plays a critical role.
Career Highlights
Banai is affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., where he continues to advance his research. His career is marked by a commitment to innovation and excellence in the pharmaceutical sector.
Collaborations
Throughout his career, Shmuel Banai has collaborated with notable colleagues, including Alexander Levitzki and Aviv Gazit. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.
Conclusion
Shmuel Banai's contributions to pharmaceutical research exemplify the spirit of innovation. His work on PDGF receptor kinase inhibitory compounds showcases his dedication to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile